¿És d'interès públic mantenir una xarxa de seguiment de ratpenats als espais naturals protegits de l'Alt Empordà?

Entre els anys 2001 a 2009 s’han realitzat diverses campanyes d’estudi de ratpenats a l’Alt Empordà, sobretot en espais naturals protegits. A banda d’unes 300 nits de camp, s’han realitzat nou conferències, s’ha editat material didàctic i generat desenes de notícies. Durant aquest període, s’han citat 25 espècies de ratpenats (86% de les catalanes). A l’Albera i l’AltaGarrotxa és on s’han trobat més espècies, segurament a causa de l’elevada diversitat d’hàbitats i presència de boscos ben conservats. Entre els diferents espais naturals, s’hi ha pogut confirmar connectivitat, sobretot gràcies als corredors fluvials amb vegetació de ribera existents. En general, aquest estudi mostra l’interès dels ratpenats com a bioindicadors de la qualitat del nostre entorn i convida investigadors i gestors a continuar fent campanyes de divulgació i sensibilitzacióBetween 2001 and 2009, several field studies on bats have been carried out in the Alt Empordà region, especially in protected areas. Besides 300 nights in the field, nine conferences were held, educational material has been edited and dozens of news articles have been published. During this period, 25 species of bats (86% of Catalan species) have been cited.Most species were found in the Albera mountain range and the Alta Garrotxa region, surely because of their elevated diversity of habitats and the presence of wellconserved forests. A connection between the different natural parks has been confirmed thanks to the river corridors and their vegetation. In general, this study is interested in bats as bioindicators of environmental quality and invites researchers and managers to continue outreach and awareness campaigns

Correction to: Cluster identification, selection, and description in Cluster randomized crossover trials: the PREP-IT trials

An amendment to this paper has been published and can be accessed via the original article

Implementing stakeholder engagement to explore alternative models of consent: An example from the PREP-IT trials

Introduction: Cluster randomized crossover trials are often faced with a dilemma when selecting an optimal model of consent, as the traditional model of obtaining informed consent from participant's before initiating any trial related activities may not be suitable. We describe our experience of engaging patient advisors to identify an optimal model of consent for the PREP-IT trials. This paper also examines surrogate measures of success for the selected model of consent. Methods: The PREP-IT program consists of two multi-center cluster randomized crossover trials that engaged patient advisors to determine an optimal model of consent. Patient advisors and stakeholders met regularly and reached consensus on decisions related to the trial design including the model for consent. Patient advisors provided valuable insight on how key decisions on trial design and conduct would be received by participants and the impact these decisions will have. Results: Patient advisors, together with stakeholders, reviewed the pros and cons and the requirements for the traditional model of consent, deferred consent, and waiver of consent. Collectively, they agreed upon a deferred consent model, in which patients may be approached for consent after their fracture surgery and prior to data collection. The consent rate in PREP-IT is 80.7%, and 0.67% of participants have withdrawn consent for participation. Discussion: Involvement of patient advisors in the development of an optimal model of consent has been successful. Engagement of patient advisors is recommended for other large trials where the traditional model of consent may not be optimal